Foresite Capital Management IV as of March 31, 2021
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 13 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 36.1 | $301M | 9.7M | 31.16 | |
| Pharvaris N V (PHVS) | 10.9 | $91M | 3.3M | 27.98 | |
| Aclaris Therapeutics (ACRS) | 10.3 | $86M | 3.4M | 25.20 | |
| Keros Therapeutics (KROS) | 10.2 | $85M | 1.4M | 61.55 | |
| Relay Therapeutics (RLAY) | 8.9 | $74M | 2.1M | 34.57 | |
| Alx Oncology Hldgs (ALXO) | 6.9 | $58M | 786k | 73.74 | |
| Kura Oncology (KURA) | 6.3 | $52M | 1.8M | 28.27 | |
| Nurix Therapeutics (NRIX) | 4.6 | $39M | 1.2M | 31.09 | |
| Cytokinetics (CYTK) | 2.5 | $21M | 882k | 23.26 | |
| Olema Pharmaceuticals (OLMA) | 1.6 | $13M | 393k | 33.18 | |
| Cymabay Therapeutics | 1.0 | $8.1M | 1.8M | 4.54 | |
| Therapeutics Acquisition Corp Com Cl A | 0.4 | $3.7M | 350k | 10.51 | |
| Decibel Therapeutics | 0.4 | $3.4M | 298k | 11.36 |
